Pharmacy Faculty Presentations

 

Follow


Presentations from 2007

Clinical Controversies, Phillip L. Thornton

Presentations from 2006

Protein Kinase C-α Mediated Downregulation of Low-Density Lipoprotein Receptor-related Protein Expression Increases Urokinase Secretion and Astrocytoma Invasion, Samson Amos, M. Mut, C. diPierro, J. E. Carpenter, A. Xiao, G. T. Redpath, Y. Zhao, J. Wang, M. E. Shaffrey, and I. M. Hussaini

Herbal Medicines: Myths, Truth and Clinical Trials - Focus on Psychotropics, Douglas C. Anderson

A Survey to Determine Influences on Pharmacy Students' Choice of Pharmacy as a Major, Douglas C. Anderson, M. C. Sheffield, A. M. Massey, and H. H. Cobb

Synthesis of Salvinorin A Analogues and Isolation of Methyl Barbascoate, J. del Rio, Denise S. Simpson, and Thomas E. Prisinzano

Atypical Antipsychotics: Are They the Answer?, Marty L. Eng

Cerebrovascular Adverse Events and the Use of Atypical Antipsychotics in Dementia Patients, Marty L. Eng

Medication Reduction and Safe Medical Prescribing for LTC Residents, Marty L. Eng

Safe Prescribing in the Elderly, Marty L. Eng

The Good, the Bad, and the OTC – PK, PD, and OTC-RX Interactions, Marty L. Eng

Where Did I Put My Cheese? Beyond Memory, Marty L. Eng

Seniors' Attitudes and Knowledge About Medicare Part D, Aleda M. Hess and D. L. Sullivan

Seniors' Attitudes and Knowledge About Medicare Part D, Aleda M. Hess and D. L. Sullivan

Seniors' Attitudes and Knowledge About Medicare Part D, Aleda M. Hess and D. L. Sullivan

Link

Synthesis of Heterocyclic Analogues of Salvinorin A, Anthony Lozama, Denise S. Simpson, Wayne W. Harding, Christina M. Dersch, Richard B. Rothman, and Thomas E. Prisinzano

Use of Technology in Medication Reconciliation, Brenda L. Pahl

Preparation of Ring D Modified Analogues of Salvinorin A, A Kappa Opioid Agonist from Salvia divinorum, Denise S. Simpson, Wayne W. Harding, Christina M. Dersch, Richard B. Rothman, and Thomas E. Prisinzano

Preparation of Ring D Modified Analogues of Salvinorin A and Evaluation of Their Activity at Opioid Receptors, Denise S. Simpson, Wayne W. Harding, Christina M. Dersch, Richard B. Rothman, and Thomas E. Prisinzano

Synthetic Modifications of the Furan Ring of Salvinorin A, a Neoclerodane Diterpene from Salvia divinorum, Denise S. Simpson, Wayne W. Harding, Christina M. Dersch, Richard B. Rothman, and Thomas E. Prisinzano

Protolimonoids, Chromones, Alkaloids, and Coumarins from Spathelia and Esenbeckia (Rutaceae), Denise S. Simpson, Helen Jacobs, and William F. Reynolds

Partners in Technology to Improve Patient Safety, Phase 2, M. A. Simpson and Marc A. Sweeney

Bioethics in the New Millennium, Dennis M. Sullivan

Complicity and Stem Cell Research: Countering the Utilitarian Argument, Dennis M. Sullivan

Ethical Controversies in Stem Cell Research, Dennis M. Sullivan

Human Personhood and Bioethics, Dennis M. Sullivan

Loving God with All Your Mind, Dennis M. Sullivan

Panel Presentation (2006), Dennis M. Sullivan

Reproductive Ethics, Dennis M. Sullivan

Stem Cell Research: Medical Promise and Moral Problems, Dennis M. Sullivan

Link

Terri Schiavo: The 'Real' Story, Dennis M. Sullivan

The Ethics of Stem Cell Research, Dennis M. Sullivan

Public Debate: Ethics of Human Embryonic Stem Cell Research (2006), Dennis M. Sullivan, R. Reese, and A. McWilliams

Assisted Suicide: Compassionate Care or Slippery Slope?, Dennis M. Sullivan, Robert Reese, and Ann McWilliams

What You Should ASK Your Pharmacist, Marc A. Sweeney

Headache Management, Marc A. Sweeney

Managing Multiple Symptoms in the End-of-Life Patient: From Pharmacology to Clinical Application, Marc A. Sweeney

Multi-sympton Management in End of Life Care, Marc A. Sweeney

New Drug Update, Marc A. Sweeney

Ohio Preceptor Training Program, Marc A. Sweeney and D. Parker

Clinical Controversies: Statin Island – How Low Should It Go?, Phillip L. Thornton

Presentations from 2005

Herbal Medicines: Myths, Truth and Clinical Trials, Douglas C. Anderson

Treating Cholesterol from Outside the Box, Douglas C. Anderson

Promoting the Practice of Drug Information in Professional Pharmacy Education, Miriam A. Ansong

Balancing Risk Factors – Statin Use in LTC, Marty L. Eng

Medication Reviews for LTC, Marty L. Eng

Running the Race – Heart Failure in LTC, Marty L. Eng

Silence Is Not Golden – Hypertension in LTC, Marty L. Eng

Link

A Survey of Coenzyme Q10 Use in Parkinson's Disease Clinic Outpatients, Marty L. Eng, K. Lyons, and R. Pahwa

LEAD: Love, Encourage, Advocate, and Be Diligent, Aleda M. Hess

Testing an Advisory Board's Role in Prescription Drug Price Regulation, Aleda M. Hess

Partners in Technology to Improve Patient Safety, M. A. Simpson and Marc A. Sweeney

Human Personhood and Bioethics, Dennis M. Sullivan

Panel Presentation, Dennis M. Sullivan

Link

Stem Cells and Moral Analogies, Dennis M. Sullivan

Teaching Bioethics Across the Disciplines: A 'Survival Kit' for Undergrads, Dennis M. Sullivan

The Heart of Medicine, Dennis M. Sullivan

Debate: Ethics of Human Embryonic Stem Cell Research, Dennis M. Sullivan, R. Reese, and A. McWilliams

Partners in Technology to Improve Patient Safety, Marc A. Sweeney

Asthma: A Review of the Disease and Its Management, Marc A. Sweeney

Can You Hear Me Now? Physicians and Pharmacists Communicating to Improve Patient Safety, Marc A. Sweeney

Reimbursement Information and Resources: When the Intervention Works, but the Patient Can't Afford It, Marc A. Sweeney

Palliative Care Certificate Program, Marc A. Sweeney, P. A. Grauer, and M. Reed

Asthma Management, Marc A. Sweeney and K. R. Lee

The Top Ten Drug Topics of 2005, Marc A. Sweeney and Marc A. Sweeney

Heart Failure and MTMS: Role of the Pharmacist, Phillip L. Thornton

Heart Failure and MTMS: Role of the Pharmacist, Phillip L. Thornton

Roundtable Discussion on Medicare Part D and MTMS, Phillip L. Thornton

The Beat Goes On…Update in Cardiology, Phillip L. Thornton

What is a Consultant Pharmacist?, Phillip L. Thornton

Presentations from 2004

COX-2 Inhibitors and Cardiovascular Risk, Douglas C. Anderson

COX-2 Inhibitors and Cardiovascular Risk, Douglas C. Anderson

Multi-Drug Therapy for the Treatment of Hyperlipidemia, Douglas C. Anderson

Preventing Medication Errors, Douglas C. Anderson

The COX-2 Inhibitors and Cardiovascular Risk, Douglas C. Anderson

Therapeutic Interventions for the Prevention or Delay of Type 2 Diabetes, Douglas C. Anderson

Therapeutic Interventions for the Prevention or Delay of Type 2 Diabetes, Douglas C. Anderson

Incorporating an Educational Trip and Review of the National Library of Medicine’s Databases in Drug Information Course to Enhance Students’ Learning: Database Overview, Miriam A. Ansong

Incorporating an Educational Trip to the National Library of Medicine into a Drug Information Course: An Approach to Enhance Students Learning, Understanding, and Effective Use of Drug Information Databases, Miriam A. Ansong

Incorporation of Experiential-Based Techniques to Augment Student Learning in a Didactic OTC Course, Miriam A. Ansong

Avoiding Adverse Drug Reactions in the Elderly, Jeffrey A. Bates

Parallel and Coordinated Teaching of Medicinal Chemistry and Integrated Pharmacology/Therapeutics and a Multidisciplinary Case-based Workshop Sequence over Two Professional Years, Bruce Currie, Nancy E. Kawahara, Rebecca J. Gryka, Barry Bleidt, and Avis Ericson

Complementary and Alternative Therapies in Dementia, Marty L. Eng

Pharmacologic Considerations in Aging, Marty L. Eng

Pharmacologic Considerations in Treatment of Diabetes in the Older Adult, Marty L. Eng

Professionalism of Ohio Northern Students, A. A. Kahaleh and Marc A. Sweeney

The Influence of Students, Faculties, and Practitioners on Professional Behavior, Abir A. Kahaleh and Marc A. Sweeney

Coordination of Medicinal Chemistry with an Integrated Pharmacology and Therapeutics Course Sequence and Combined Recitation, Nancy E. Kawahara, Rebecca J. Gryka, Barry Bleidt, Avis Ericson, and Bruce Currie

A Behind-the-Scenes Look at Drug Interactions, Jeffrey D. Lewis

A Behind-the-Scenes Look at Drug Interactions, Jeffrey D. Lewis

Link

The Impact of Comorbidity on Inappropriate Community-based Services, S. Rigler, T. I. Shireman, S. Perera, C. Jachna, and Marty L. Eng

Link

Where Do Medicaid Drug Dollars Go? An Analysis of Newer Pharmaceuticals Across Diverse Drug Classes, S. Rigler, T. Shireman, C. Jachna, T. Griebling, and Marty L. Eng

Improving Diabetic Patient Care Using Pharmacist-supervised Disease State Management, J. E. Stanovich, D. Stansloski, and Marc A. Sweeney

Antimicrobial Resistance Trends, Marc A. Sweeney

Bases Loaded...Pharmacists Are Up to Bat, Marc A. Sweeney

Implications for Curricular Professional Experience, Marc A. Sweeney

Review of Neurologic and Psychiatric Drug Therapy, Marc A. Sweeney

The Clinical Significance of Drug Interactions, Marc A. Sweeney

Can You Hear Me Now? Physicians and Pharmacists Communicating to Improve Patient Safety, Marc A. Sweeney and M. Simpson

Can You Hear Me Now? Physicians and Pharmacists Communicating to Improve Patient Safety, Marc A. Sweeney and M. Simpson

Can You Hear Me Now? Physicians and Pharmacists Communicating to Improve Patient Safety, Marc A. Sweeney and M. Simpson